Abstract
Background Coronavirus disease (COVID-19) is an infectious disease that is caused by the SARS-CoV-2virus. The objective of this study was to determine SARS COV-2 Mortality and its associated factors in East Shewa Zone Treatment centers, Oromia, Ethiopia, 2022. The study of these types of viral infection will add new insight into the most common causes of mortality in SARS-CoV-2infection and the most common co-morbidities associated with the disease in the East Shewa Zone.
Methods The study was conducted on patients who were admitted to Adama Hospital medical college and Modjo Primary Hospital for SARS-COV 2 treatment. Data used for the study were collected from March 2020-April 2022 GC. The study population was SARS-COV 2 patients who come to Adama Hospital and Medical College and Modjo Primary Hospital for treatment. All eligible SARS-CoV-2 patients’ data were collected from Both Adama and Modjo treatment center SARS-CoV-2 accession registration book and medical record card.
Result A total of 409 patient data were collected from which 199 were from Adama Hospital and Medical College and 210 samples were collected from Modjo Primary Hospital Treatment center. The study design was a retrospective Cross-sectional study. The most affected age group in terms of mortality was the age group between 60-69 years old which suffers a 45.28% death rate. The major sign symptoms identified include cough (80.4%), Shortness of breath (66.7%) followed by fever (43.2%). SARS-CoV-2 Comorbidity was detected in 152 (37.2%) patients. Pneumonia was identified as the major comorbid disease to be recorded with 89(21.8%) cases. Other major comorbidities include Hypertension (16.9%) and Diabetes Mellites (13.9%). The least identified comorbidities were anemia (0.2%), Rectal cancer (0.2%), breast cancer (0.5%), and Chronic liver disease.
Conclusion Nearly one in four (22.7%) SARS-COV 2 patients admitted for treatment to Adama Hospital and Medical College and Modjo Primary Hospital did not make their way out of treatment Hospitals alive. Pneumonia was identified as the major comorbid disease to be recorded with 89(21.8%) cases
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Adama Public Health Research and Referral Laboratory Center
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approvals were waived by Oromia Regional Health bureau Health Research Ethical Committe. Ethical approval original local language protocol Number BFO/MOTFYH/1-16/100009
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data set used in this study are available upon request from editorial manager of other relevant body upon request
Abbreviations
- AC
- Anticoagulant
- AHMC
- Adama Hospital Medical College
- AKI
- Acute Kidney Injury
- ALP
- Alkaline phosphatase
- ALT
- Alanine transaminase
- APHRRLC
- Adama Public Health Research and Referral laboratory Center
- ARDS
- Acute Respiratory Distress Syndrome
- AST
- Aspartate Aminotransferase
- BSC
- Bachelor of Science
- BUN
- Blood Urea Nitrogen
- Ca
- Calcium
- CA
- Cancer
- CDC
- Center For Disease Control and Prevention, USA
- CHF
- Cardiac Heart Failure
- CLD
- Chronic Liver Disease
- CLD
- Chronic Liver Disease
- CNS
- Central Nervous System
- COPD
- Chronic obstructive pulmonary disease
- COVID 19
- Coronavirus 19
- CSA
- Central statistics Agency, Ethiopia
- CT
- computerized tomography
- CVD
- Cardio Vascular Disease
- CXR
- Chest X ray
- DM
- Diabetes Mellitus
- EC
- Ethiopian Calendar
- EPIINFO
- Epidemiological Information
- HIV
- Human Immuno deficiency Virus
- HTN
- Hypertension
- IBM SPSS
- International Business Machines, Statistical Package for Social Sciences
- ICU
- Intensive Care Unit
- IQR
- Inter quartile Range
- IRB
- Institutional review board
- K
- Potassium
- LOS
- Length of Stay
- MPH
- Masters of Public Health
- Na
- Sodium
- NYC
- New York City
- P VALUE
- Probability value
- SARS
- COV2 Severe Acute Respiratory Syndrome - Corona Virus - 2 sCr Serum Creatinine
- SGOT
- serum glutamic-oxaloacetic transaminase
- SGPT
- Serum Glutamic Pyruvic Transaminase
- SOB
- Shortness of breath
- TB
- Tuberculosis
- UHF
- Unfractionated Heparin
- UK
- United Kingdom
- USA
- United States of America
- VBM
- Variant Being Monitored
- VOC
- Variant of Concern
- VOHS
- Variant of High Consequence
- VOI
- Variant of Interest
- WBC
- White Blood Cell
- WHO
- World Health Organization
